• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Novo Nordisk

Rotten tomato splat fruit
Special Reports

Fierce Biotech's Rotten Tomatoes of 2025

Which stories from the year represented strategic missteps, chaotic management or just rotten luck?
James Waldron , Darren Incorvaia Dec 16, 2025 4:30am
pedal to metal fast car speed gas

Novo expands pivotal program after amycretin shines in diabetes

Nov 25, 2025 7:44am
Novo Nordisk
Favicon Fierce Pharma

Novo reports 2 trial failures for GLP-1 in Alzheimer's disease

Nov 24, 2025 11:41am
stack of letters mail envelopes

Pfizer finalizes Metsera buy after contentious Novo bidding war

Nov 13, 2025 12:43pm
bumpy road rough bad path

Korro lays off staff as lead drug disappoints, Novo pauses pact

Nov 13, 2025 7:20am
positive negative up down good bad mixed

Novo Nordisk shares mixed data behind pivotal heart disease push

Nov 11, 2025 8:32am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings